To hear about similar clinical trials, please enter your email below
Trial Title:
Thromboelastography During Surgery for Malignant Pleural Mesothelioma
NCT ID:
NCT01912547
Condition:
Coagulopathy
Mesothelioma
Conditions: Official terms:
Mesothelioma
Mesothelioma, Malignant
Study type:
Observational
Overall status:
Unknown status
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Procedure
Intervention name:
Blood draw for TEG analysis
Description:
Blood drawn for TEG analysis
Arm group label:
Blood draw for TEG analysis
Summary:
Surgery for malignant pleural mesothelioma is complex and prolonged, and may involve
significant blood loss with considerable blood and product transfusion.
Thromboelastography (TEG) is a global assay of coagulation that uses whole blood to
produce a tracing that records kinetic changes in clot formation. This study aims provide
a better understanding of the coagulation profile of these patients, and will form the
basis of a TEG-based transfusion algorithm for future surgeries for mesothelioma.
Detailed description:
Thromboelastography can provide more in-depth and quicker analysis of the complex
coagulation processes during surgery
Criteria for eligibility:
Study pop:
Adult patients undergoing surgery for malignant pleural mesothelioma
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Adult male or female patients undergoing elective surgery for malignant pleural
mesothelioma
Exclusion Criteria:
- Unwilling or unable to provide consent
- History of bleeding disorder
- On medications that may affect hemostasis
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
Brigham and Women's Hospital
Address:
City:
Boston
Zip:
02115
Country:
United States
Status:
Recruiting
Contact:
Last name:
Ju-Mei Ng, MD
Phone:
617-732-8219
Email:
jng1@partners.org
Investigator:
Last name:
Ju-Mei Ng
Email:
Principal Investigator
Start date:
September 2013
Completion date:
December 2015
Lead sponsor:
Agency:
Brigham and Women's Hospital
Agency class:
Other
Source:
Brigham and Women's Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT01912547
